Hyperthyroidism Samples
239 Products
Human Serum - Calcitonin, Thyrotropin (TSH), Thyrox... - E05.9
- Donor:
- Gender: Female Age: 54 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.9 - Thyrotoxicosis, unspecified
- Medication:
- L-thyroxine
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 p24 (HIV-1/2 p24) Anti-Thyroid peroxidase (aTPO / MAK) Calcitonin Hepatitis B Virus surface Antigen (HBsAg) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 54 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 27 kg/m²
- Weight:
- 76 kg
- Height:
- 167 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis, unspecified [E05.9]
- hypertension
Medication:
- L-thyroxine (Dosages: 100mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
Remarks: 3rd generation |
negative
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas Roche |
| Anti-Human Immunodeficiency Virus-1/2 p24 (HIV-1/2 p24) |
Qual: negative
Quant:
Source: this donation
Remarks: Roche-Combi 4th generation |
negative
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: not specified Roche |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: < 10.00 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Calcitonin |
Qual:
Quant: 2.39 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: not specified Roche |
| Thyrotropin (TSH) |
Qual: negative
Quant: 1.08 mU/L
Source: this donation
Remarks: basal |
0.35 - 4.94 mU/L
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Thyrotropin (TSH) |
Qual: negative
Quant: 1.32 mU/L
Source: this donation
Remarks: sensitive |
0.27 - 4.20 mU/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 e-Module Roche |
| Thyrotropin (TSH) |
Qual:
Quant: 6.77 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 14.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.60 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH143002
1 mL (€37.50)
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Male Age: 37 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Anti-Syphilis (Treponema pallidum) Anti-Thyroid peroxidase (aTPO / MAK) Hepatitis B Virus surface Antigen (HBsAg) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 37 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 25 kg/m²
- Weight:
- 82 kg
- Height:
- 180 cm
Sample:
- Matrix:
- Serum
- Condition:
- slightly lipemic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- Graves orbitopathy
- hypothyroidism
Medication:
- L-thyroxine (Dosages: 150mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Syphilis (Treponema pallidum) |
Qual: negative
Quant: < 1: 80 Titer
Source: this donation
|
80 Titer
|
System: not specified not specified |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 5.70 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
System: Architect i 2000 sr Abbott Diagnostics |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 13.63 U/L
Source: this donation
|
< 1.75 U/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas E170 Roche |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 13.50 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 1.46 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 13.10 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 5.90 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH143479
1 mL (€37.50)
Human Serum - TSH Receptor Antibodies (TRAb), TSH R... - E05.0
- Donor:
- Gender: Female Age: 52 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- Bisoprolol
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Anti-Syphilis (Treponema pallidum) Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Hepatitis B Virus surface Antigen (HBsAg) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3) ...
Donor:
- Gender:
- Female
- Age:
- 52 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 78 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- hypertension
- tinnitus
Medication:
- Bisoprolol (Dosages: 2.5mg)
- Valsartan (Dosages: 80mg)
- thiamazole (Dosages: 10mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Syphilis (Treponema pallidum) |
Qual: negative
Quant: < 1: 80 Titer
Source: this donation
|
80 Titer
|
System: not specified not specified |
| Anti-Thyroglobulin (aTg / TAK) |
Qual: negative
Quant: < 20.00 kU/L
Source: this donation
|
< 40.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: < 10.00 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
System: Architect i 2000 sr Abbott Diagnostics |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 9.31 IU/L
Source: this donation
|
< 1.80 IU/L
|
Method: FIA (Fluorescence Immuno Assay) System: Kryptor Thermo Fisher (Brahms) |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 11.80 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual: negative
Quant: < 0.005 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 13.50 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 6.70 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284567
1 mL (€37.50)
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 34 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.9 - Thyrotoxicosis, unspecified
- Medication:
- Dociton
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Hepatitis B Virus surface Antigen (HBsAg) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 34 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 33 kg/m²
- Weight:
- 92 kg
- Height:
- 166 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- Thyrotoxicosis, unspecified [E05.9]
Medication:
- Dociton (Dosages: 40mg)
- Trigoa
- thiamazole (Dosages: 10mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Thyroglobulin (aTg / TAK) |
Qual: negative
Quant: < 20.00 kU/L
Source: this donation
|
< 40.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: 24.50 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 135.00 U/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 16.76 IU/L
Source: this donation
|
< 1.80 IU/L
|
Method: FIA (Fluorescence Immuno Assay) System: Kryptor Thermo Fisher (Brahms) |
| Thyrotropin (TSH) |
Qual: negative
Quant: < 0.05 mU/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 16.80 ng/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 8.80 ng/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283360
1 mL (€37.50)
Human K2EDTA plasma - TSH Receptor Antibodies (TRAb), Thyro... - E05.0
- Donor:
- Gender: Female Age: 55 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 55 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 24 kg/m²
- Weight:
- 68 kg
- Height:
- 170 cm
Sample:
- Matrix:
- K2EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- arthrosis - lumbar vertebra L5/L6, thumb basal joint (not specified)
Medication:
- L-thyroxine (Dosages: 137not specified)
- selenium (Dosages: 100µg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: < 0.25 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 31.30 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: positive
Quant: 0.11 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 14.80 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.08 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147024
1 mL (€37.50)
Human K3EDTA plasma - TSH Receptor Antibodies (TRAb), Thyro... - E05.0
- Donor:
- Gender: Female Age: 55 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 55 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 24 kg/m²
- Weight:
- 68 kg
- Height:
- 170 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- arthrosis - lumbar vertebra L5/L6, thumb basal joint (not specified)
Medication:
- L-thyroxine (Dosages: 137not specified)
- selenium (Dosages: 100µg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: < 0.25 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 31.30 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: positive
Quant: 0.11 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 14.80 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.08 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147026
1 mL (€37.50)
Human Serum - Anti-cyclic citrullinated Peptide (CC... - E05.0
- Donor:
- Gender: Female Age: 64
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- Prednisolon
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Human anti-mouse Antibodies (HAMA) Rheumatoid Factor (RF)
Donor:
- Gender:
- Female
- Age:
- 64 Years
- BMI:
- 24 kg/m²
- Weight:
- 68 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Serum
- Condition:
- not specified
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Anamneses:
- Tender Joint Count (TJC) at the time of donation 0 (19.07.2018)
- Tender Joint Count (TJC) at the time of donation 0 (19.07.2018)
- Tender Joint Count (TJC) at the time of donation 0 (19.07.2018)
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- Prednisolon (Dosages: 2mg)
- RoActemra (Dosages: 560mg/4 weeks)
- adalimumab
- etanercept
- infliximab
- pravastatin (Dosages: 20mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual:
Quant: 31.70 IU/mL
Source: previous donation
|
not specified not specified
|
System: not specified not specified |
| Capsule-reactive protein (CRP) |
Qual:
Quant: 1.23 mg/L
Source: previous donation
|
not specified not specified
|
System: not specified not specified |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 18.00 mm/1h
Source: previous donation
|
not specified not specified
|
System: not specified not specified |
| Human anti-mouse Antibodies (HAMA) |
Qual: positive
Quant: 46.52 ng/mL
Source: previous donation
Remarks: gemessen in I100355263 |
< 40.00 ng/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: MTP Photometer BioTek |
| Rheumatoid Factor (RF) |
Qual:
Quant: 175.00 IU/mL
Source: previous donation
|
not specified not specified
|
System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284591
1 mL (€37.50)
Human Sodium heparin plasma - TSH Receptor Antibodies (TRAb), Thyro... - E05.0
- Donor:
- Gender: Female Age: 55 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 55 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 24 kg/m²
- Weight:
- 68 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Sodium heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- arthrosis - lumbar vertebra L5/L6, thumb basal joint (not specified)
Medication:
- L-thyroxine (Dosages: 137not specified)
- selenium (Dosages: 100µg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: < 0.25 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 31.30 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: positive
Quant: 0.11 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 14.80 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.08 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147028
1 mL (€37.50)
Human Li-heparin plasma - TSH Receptor Antibodies (TRAb), Thyro... - E05.0
- Donor:
- Gender: Female Age: 55 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 55 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 24 kg/m²
- Weight:
- 68 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- arthrosis - lumbar vertebra L5/L6, thumb basal joint (not specified)
Medication:
- L-thyroxine (Dosages: 137not specified)
- selenium (Dosages: 100µg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: < 0.25 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 31.30 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: positive
Quant: 0.11 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 14.80 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.08 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147027
1 mL (€37.50)
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 53 Ethnic group: Not specified
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 53 Years
- Ethnic group:
- Not specified
- BMI:
- 20 kg/m²
- Weight:
- 51 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- slightly hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 100not specified)
- Prednisolon (Dosages: 500mg)
- Vigantoletten (Dosages: 1000mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 176.90 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 27.77 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.01 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 9.50 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147491
1 mL (€37.50)
Human K2EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 53 Ethnic group: Not specified
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 53 Years
- Ethnic group:
- Not specified
- BMI:
- 20 kg/m²
- Weight:
- 51 kg
- Height:
- 158 cm
Sample:
- Matrix:
- K2EDTA plasma
- Condition:
- hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 100not specified)
- Prednisolon (Dosages: 500mg)
- Vigantoletten (Dosages: 1000mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 176.90 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 27.77 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.01 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 9.50 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH122647
1 mL (€37.50)
Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 53 Ethnic group: Not specified
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 53 Years
- Ethnic group:
- Not specified
- BMI:
- 20 kg/m²
- Weight:
- 51 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 100not specified)
- Prednisolon (Dosages: 500mg)
- Vigantoletten (Dosages: 1000mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 176.90 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 27.77 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.01 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 9.50 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH122649
1 mL (€37.50)
Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 53 Ethnic group: Not specified
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 53 Years
- Ethnic group:
- Not specified
- BMI:
- 20 kg/m²
- Weight:
- 51 kg
- Height:
- 158 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- slightly hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 100not specified)
- Prednisolon (Dosages: 500mg)
- Vigantoletten (Dosages: 1000mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 176.90 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 27.77 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.01 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 9.50 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH122648
1 mL (€37.50)
Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 53 Ethnic group: Not specified
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 53 Years
- Ethnic group:
- Not specified
- BMI:
- 20 kg/m²
- Weight:
- 51 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Sodium heparin plasma
- Condition:
- hemolytic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 100not specified)
- Prednisolon (Dosages: 500mg)
- Vigantoletten (Dosages: 1000mg)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 176.90 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 27.77 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.01 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 9.50 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH122650
1 mL (€37.50)
Human K2EDTA plasma - TSH Receptor Antibodies (TRAb) - E05.0
- Donor:
- Gender: Female Age: 50 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 50 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 60 kg
- Height:
- 174 cm
Sample:
- Matrix:
- K2EDTA plasma
- Condition:
- slightly lipemic
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 125mg)
- selenium
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: 3.00 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 11.40 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: negative
Quant: 2.35 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 13.50 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.03 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147015
1 mL (€37.50)
Human K3EDTA plasma - TSH Receptor Antibodies (TRAb) - E05.0
- Donor:
- Gender: Female Age: 50 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 50 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 60 kg
- Height:
- 174 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- slightly lipemic
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 125mg)
- selenium
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: 3.00 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 11.40 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: negative
Quant: 2.35 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 13.50 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.03 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147018
1 mL (€37.50)
Human Li-heparin plasma - TSH Receptor Antibodies (TRAb) - E05.0
- Donor:
- Gender: Female Age: 50 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 50 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 60 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- slightly lipemic
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 125mg)
- selenium
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: 3.00 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 11.40 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: negative
Quant: 2.35 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 13.50 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.03 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147020
1 mL (€37.50)
Human Sodium heparin plasma - TSH Receptor Antibodies (TRAb) - E05.0
- Donor:
- Gender: Female Age: 50 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 50 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 60 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Sodium heparin plasma
- Condition:
- slightly lipemic
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 125mg)
- selenium
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: 3.00 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 11.40 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: negative
Quant: 2.35 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 13.50 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.03 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147023
1 mL (€37.50)
Human Serum - TSH Receptor Antibodies (TRAb) - E05.0
- Donor:
- Gender: Female Age: 50 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 50 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 60 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Serum
- Condition:
- slightly lipemic
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 125mg)
- selenium
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: 3.00 IU/ml
Source: previous donation
|
< 35.00 IU/ml
|
Method: not specified System: Access TPO Ab Beckman Coulter |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 11.40 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trak Human RIA Thermo Fisher Scientific |
| Thyrotropin (TSH) |
Qual: negative
Quant: 2.35 mlU/l
Source: previous donation
|
0.30 - 4.20 mlU/l
|
Method: not specified System: Access TSH (3rd IS) Beckman Coulter |
| Thyroxine (FT4) |
Qual: negative
Quant: 13.50 pmol/l
Source: previous donation
|
7.00 - 21.10 pmol/l
|
Method: not specified System: Acces Freies T4 Beckman Coulter |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 4.03 pmol/L
Source: previous donation
|
3.53 - 6.30 pmol/L
|
Method: not specified System: Acces Freies T3 Beckman Coulter |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147013
1 mL (€37.50)
Human Serum - TSH Receptor Antibodies (TRAb), TSH R... - E05.06
- Donor:
- Gender: Female Age: 27 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- Novorapid
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg) TSH Receptor Antibodies (TRAb)
Donor:
- Gender:
- Female
- Age:
- 27 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 81 kg
- Height:
- 171 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- E05.06
- Thyrotoxicosis with diffuse goitre [E05.0]
- diabets mellitus - type 1 (not specified)
Medication:
- Novorapid (Dosages: 60IU, active agent: insulin aspart)
- thiamazole (Dosages: 15mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant: -
Source: this donation
|
negative -
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 17.000 IU/L
Source: previous donation
|
0.00 - 1.00 IU/L
|
Method: not specified System: Trakoman RIA Thermo Fisher Scientific |
| TSH Receptor Antibodies (TRAb) |
Qual: positive
Quant: 18.43 U/L
Source: this donation
|
< 1.58 U/L
Remarks: borderline: 1,58 1,75 |
System: Cobas Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH293874
1 mL (€37.50)
Human Serum - Thyrotropin (TSH), Thyrotropin (TSH),... - E05.0
- Donor:
- Gender: Female Age: 33 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.9 - Thyrotoxicosis, unspecified
- Medication:
- L-thyroxine
- Parameter:
- TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 33 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 25 kg/m²
- Weight:
- 64 kg
- Height:
- 161 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- Thyrotoxicosis, unspecified [E05.9]
Medication:
- L-thyroxine (Dosages: 150µg/day)
- Quetiapin (Dosages: 50mg/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| TSH Receptor Antibodies (TRAb) |
Qual: negative
Quant: 0.33 IU/L
Source: previous donation
|
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75 |
Method: not specified System: Cobas Modular Roche |
| Thyrotropin (TSH) |
Qual: positive
Quant: 0.156 mU/L
Source: this donation
Remarks: sensitive |
0.270 - 4.200 mU/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 e-Module Roche |
| Thyrotropin (TSH) |
Qual: positive
Quant: 0.15 mIU/L
Source: previous donation
|
0.27 - 4.20 mIU/L
|
Method: not specified System: not specified Roche |
| Thyroxine (FT4) |
Qual: positive
Quant: 22.10 pg/mL
Source: previous donation
|
9.30 - 17.00 pg/mL
|
Method: not specified System: not specified Roche |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 3.50 pg/mL
Source: previous donation
|
2.00 - 4.40 pg/mL
|
Method: not specified System: not specified Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292142
1 mL (€37.50)
Human EDTA plasma - Glucose, Hemoglobin (Hb) - E05.1
- Donor:
- Gender: Female Age: 59
- Diagnosed disease:
- E05.1 - Thyrotoxicosis with toxic single thyroid nodule
- Medication:
- L-thyroxine
- Parameter:
- Cancer-Antigen 19-9 (CA 19-9) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb)
Donor:
- Gender:
- Female
- Age:
- 59 Years
- BMI:
- 24 kg/m²
- Weight:
- 60 kg
- Height:
- 158 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with toxic single thyroid nodule [E05.1]
Medication:
- L-thyroxine
- Pantozol
- bisoprolol
- metformin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 14.70 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 120.00 mg/dl
Source: this donation
|
74 - 106 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: negative
Quant: 18.00 U/L
Source: this donation
|
Okt 35 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: negative
Quant: 26.00 U/L
Source: this donation
|
Okt 35 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: I100489535
Quant: 13.30 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290527
0.5 mL (€18.75)
Human Li-heparin plasma - Erythrocyte sedimentation rate (ESR) ... - E05.1R
- Donor:
- Gender: Female Age: 46 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.1R
- Medication:
- Dekristol
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 46 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 60 kg
- Height:
- 173 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- E05.1R
Medication:
- Dekristol (Dosages: 20000/2 weeks, acitve agent: vitamin D3)
- L-thyroxine (Dosages: 75not specified)
- Olumiant (Dosages: 4mg/day, active agent: baricitinib)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: 12.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.34 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.40 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 9.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: positive
Quant: 22.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 20.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294672
1 mL (€37.50)
Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - E05.1R
- Donor:
- Gender: Female Age: 46 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.1R
- Medication:
- Dekristol
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 46 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 60 kg
- Height:
- 173 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- E05.1R
Medication:
- Dekristol (Dosages: 20000/2 weeks, acitve agent: vitamin D3)
- L-thyroxine (Dosages: 75not specified)
- Olumiant (Dosages: 4mg/day, active agent: baricitinib)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: 12.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.34 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.40 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 9.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: positive
Quant: 22.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 20.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294668
1 mL (€37.50)
Human Serum - Anti-Thyroglobulin (aTg / TAK), Anti-... - E05.0
- Donor:
- Gender: Female Age: 29 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- thiamazole
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Hepatitis B Virus surface Antigen (HBsAg) TSH Receptor Antibodies (TRAb) Thyroglobulin (Tg) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3) ...
Donor:
- Gender:
- Female
- Age:
- 29 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 75 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Graves disease [E05.0]
- hyperthyreosis
Medication:
- thiamazole (Dosages: 2.5mg/2 days)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Thyroglobulin (aTg / TAK) |
Qual: positive
Quant: 197.95 IU/mL
Source: this donation
|
< 100 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: positive
Quant: 559.00 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 583.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 0.76 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroglobulin (Tg) |
Qual: positive
Quant: 1.92 ng/mL
Source: this donation
|
2.00 - 70.00 ng/mL
|
Method: LIA (Luminescence Immuno Assay) System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.44 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 11.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 4.80 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH180285
103 mL (€3,862.50)
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 41
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-Thyrox
- Parameter:
- Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyroglobulin (Tg) Thyrotropin (TSH) Thyroxine (FT4) Triglycerides Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 41 Years
- BMI:
- 32 kg/m²
- Weight:
- 87 kg
- Height:
- 164 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- Graves disease
Medication:
- L-Thyrox (Dosages: 150µg)
- bisoprolol (Dosages: 5mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroglobulin (aTg / TAK) |
Qual: negative
Quant: < 50.00 IU/mL
Source: this donation
|
< 100 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: negative
Quant: 34.00 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 56.00 IU/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual: negative
Quant: < 0.30 IU/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroglobulin (Tg) |
Qual: positive
Quant: 1.72 ng/mL
Source: this donation
|
2.00 - 70.00 ng/mL
|
Method: LIA (Luminescence Immuno Assay) System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 1.64 µIU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 12.90 pg/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triglycerides |
Qual: negative
Quant: 1.39 mmol/L
Source: this donation
|
< 2.25 mmol/L
|
Method: not specified System: not specified Beckman Coulter |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.90 pg/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292451
1 mL (€37.50)
Human Serum - Thyrotropin (TSH), Thyroxine (FT4), T... - E05.0
- Donor:
- Gender: Female Age: 44 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- Enbrel
- Parameter:
- Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 44 Years
- Ethnic group:
- European/Caucasian
- Height:
- 170 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Graves disease [E05.0]
- Graves orbitopathy
- psoriasis - skin and joints (not specified)
- reflux disease - NERD (not specified)
Medication:
- Enbrel (Dosages: 50mg/week)
- Novothyral (alternating dosages)
- folic acid (Dosages: 5mg/week)
- methotrexate (Dosages: 15mg/week)
Therapy:
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Thyrotropin (TSH) |
Qual:
Quant: 0.04 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 16.40 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.90 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH180412
217 mL (€8,137.50)
Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 18 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 18 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 22 kg/m²
- Weight:
- 63 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Sodium heparin plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 37.5mg)
- thiamazole (Dosages: 2.5mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 347.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 4.19 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.93 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 12.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH123479
1 mL (€37.50)
Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 18 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 18 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 22 kg/m²
- Weight:
- 63 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 37.5mg)
- thiamazole (Dosages: 2.5mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 347.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 4.19 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.93 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 12.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH123478
1 mL (€37.50)
Human K2EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Female Age: 18 Ethnic group: European/Caucasian
- Diagnosed disease:
- E05.0 - Thyrotoxicosis with diffuse goitre
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 18 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 22 kg/m²
- Weight:
- 63 kg
- Height:
- 170 cm
Sample:
- Matrix:
- K2EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
Medication:
- L-thyroxine (Dosages: 37.5mg)
- thiamazole (Dosages: 2.5mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 347.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 4.19 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.93 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 12.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH123476
1 mL (€37.50)
